M
Miia Kivipelto
Researcher at Karolinska University Hospital
Publications - 516
Citations - 70761
Miia Kivipelto is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Dementia & Population. The author has an hindex of 91, co-authored 447 publications receiving 58328 citations. Previous affiliations of Miia Kivipelto include National Institute for Health and Welfare & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
The WW‐FINGERS‐SARS‐CoV‐2 initiative: a multinational survey to assess the effects of the COVID‐19 Pandemic on Lifestyle and Psychosocial factors relevant to Brain Health
Francesca Mangialasche,Ana Sabsil Lopez Rocha,Jenni Lehtisalo,Alina Solomon,Lefkos T. Middleton,Charlotta Thunborg,Nicholas Levak,Celeste A. de Jager,Geraint Price,Anders Rydström,Tiia Ngandu,Miia Kivipelto +11 more
TL;DR: The World Wide Fingers (WW•FINGERS) global network of multidomain trials for dementia risk reduction and prevention is at the forefront of efforts to find effective and sustainable solutions for diverse population as mentioned in this paper .
Journal ArticleDOI
Markers of vitamin B12 status in relation to cerebrospinal fluid biomarkers of Alzheimer's disease and cognitive performance.
Babak Hooshmand,Patrick Fissler,Robert Perneczky,Markus Otto,Hayrettin Tumani,Miia Kivipelto,Christine A. F. von Arnim +6 more
TL;DR: In this paper , the association between markers of vitamin B12 status and cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) which precede cognitive impairment has been investigated by only a few small studies and results have been inconsistent.
Journal ArticleDOI
Memory clinic clinicians’ preferences and needs for communication with patients: A multi‐national survey study from EU‐FINGERS & LETHE projects
Heleen M.A. Hendriksen,Aniek M van Gils,Miia Kivipelto,Francesca Mangialasche,Hanneke F.M. Rhodius-Meester,Ellen M. A. Smets,Wiesje M. van der Flier,Leonie N.C. Visser +7 more
TL;DR: In this paper , the authors identify their perspectives on communicating about diagnostic testing, biomarker test results, dementia risk, and prevention, and inventory their need for communication support to assist clinicians in these challenges.
Journal ArticleDOI
Blood β-synuclein is related to amyloid PET positivity in memory clinic patients.
Patrick Oeckl,Marina Blūma,M. Bucci,Steffen Halbgebauer,Konstantinos Chiotis,Anna Sandebring-Matton,Nicholas J. Ashton,Lana Grötschel,Miia Kivipelto,Kaj Blennow,Henrik Zetterberg,Irina Savitcheva,Agneta Nordberg,Markus Otto +13 more
TL;DR: In this article , the association of plasma β-synuclein levels with flutemetamol positron emission tomography (PET) in patients with Alzheimer's disease (AD), mild cognitive impairment (MCI), and non-demented controls was investigated.